Oncology RWE Lead: Medical Evidence & Access Strategy

Pubblicato il 05-11-2026 · AstraZeneca · Bardi

pAstraZeneca plc is seeking a Medical Evidence Advisor Oncology in Italy to lead RWE strategy for prioritized brands and to secure patient access. You will design end-to-end RWE programs, coordinate between medical, market access and commercial teams, and oversee observational studies and governance. /ppYou will translate health outcomes into value propositions, support oncology strategies, and ensure compliance with ethics and data protection. /p #J-18808-Ljbffr
Max. 8 MB. Formati Accettati: PDF, RTF, DOC, DOCX, ODT.